Latest Posts

22

Apr 24

Partex Partners with Lupin to Revolutionize Drug Discovery through AI-Driven Asset Search and Evaluation

Frankfurt, Germany, 23 April 2024 – Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to...
Read More

27

Mar 24

Partex NV announces collaboration with Althea DRF Lifesciences to provide comprehensive end-to-end services to accelerate drug discovery and development

Frankfurt, Germany; 28 March 2024 – Partex Group, a pioneer in AI-driven drug discovery, announces a collaboration with Althea DRF...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More

INVESTORS

With the technological expertise in the areas of artificial intelligence and blockchain as well as its proficiency in Lifesciences, Innoplexus builds the fundament of Partex. 

Partex is redefining healthcare to become a lean digital pharma.

You will be rerouted to Partex, the legal entity handling the financial investments for the entire group.